Patent application number | Description | Published |
20080207495 | CYCLOSPORIN COMPOSITIONS FOR OCULAR ROSACEA TREATMENT - Disclosed herein are methods of treating ocular rosacea with cyclosporin A. Compositions and medicaments related thereto are also disclosed. | 08-28-2008 |
20090298753 | METHODS FOR THE THERAPEUTIC USE OF CYCLOSPORINE COMPONENTS - Methods of treating humans or animals having various conditions are disclosed which include administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the condition. Among the conditions treated are systemic lupus eryhematosis, multiple sclerosis, maloplabia of the skin, oral frictional hyperkeratosis, oral manifestations of autoimmune blistering disease, oral lichen planus, aphthous ulcers, nasal polyps, rhinosporiodosis, sinusitis, iritis, carcinoid lung, laryngitis and atrophic gastritis. | 12-03-2009 |
20100305037 | CYCLOSPORIN DERIVATIVES FOR TREATING INFLAMMATORY DISEASES AND CONDITIONS - The present invention provides a method for the treatment of inflammatory diseases and/or conditions, e.g. allergic conjunctivitis, uveitis or phacoanaphylactic endophthalmitis in an eye of a mammal, said method comprising administering to said mammal in need of treatment a therapeutically effective amount of a novel cyclosporin A derivative selected from the group consisting of compounds represented by the formula: | 12-02-2010 |
20110223169 | IL-17 ANTIBODY INHIBITOR FOR TREATING DRY EYE - Disclosed herein is a method of treating dry eye with an IL-17 antibody. | 09-15-2011 |
20110223170 | KLK-13 ANTIBODY INHIBITOR FOR TREATING DRY EYE - Disclosed herein is a method of treating dry eye with a KLK-13 antibody. | 09-15-2011 |
20110311527 | IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS - Disclosed herein is a method of treating certain ocular and other diseases with an anti-IL-23p19 antibody. | 12-22-2011 |
20110312886 | TGF- AND METHODS OF TREATING OCULAR AND OTHER DISEASES - Disclosed herein is a method of treating ocular and systemic conditions by administering a TGF-β. | 12-22-2011 |
20110318303 | IL-10 AND METHODS OF TREATING OCULAR AND OTHER DISEASES - Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides. | 12-29-2011 |
20120088734 | Cyclosporin Analogs - Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions. | 04-12-2012 |
20120135939 | Cyclosporin Analogs - Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions. | 05-31-2012 |
20120276106 | KLK-13 ANTIBODY INHIBITOR FOR TREATING DRY EYE - Disclosed herein is a method of treating dry eye with a KLK-13 antibody. | 11-01-2012 |
20130323202 | METHODS OF TREATING OCULAR AND OTHER DISEASES WITH SYN-134R POLYPEPTIDE - Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides. | 12-05-2013 |
20140005124 | CYCLOSPORIN DERIVATIVES FOR TREATING INFLAMMATORY DISEASES AND CONDITIONS | 01-02-2014 |
20140017245 | KLK-13 ANTIBODY INHIBITOR FOR TREATING DRY EYE - Disclosed herein is a method of treating dry eye with a KLK-13 antibody. | 01-16-2014 |
20150065433 | CYCLOSPORIN ANALOGS - Disclosed herein are novel analogs of cyclosporin, pharmaceutical compositions containing them, and methods for their use in the treatment of dry eye and other conditions. | 03-05-2015 |